| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-cancer vaccine therapy for hematologic malignancies: An evolving era
|
Nahas, Myrna R.
|
|
2018
|
32 |
4 |
p. 312-325
|
artikel
|
| 2 |
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
|
Cappellini, Maria Domenica
|
|
2018
|
32 |
4 |
p. 300-311
|
artikel
|
| 3 |
Bispecific antibody based therapeutics: Strengths and challenges
|
Thakur, Archana
|
|
2018
|
32 |
4 |
p. 339-347
|
artikel
|
| 4 |
Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managing
|
Medeiros, Bruno C.
|
|
2018
|
32 |
4 |
p. 289-299
|
artikel
|
| 5 |
Consequences of dysregulated complement regulators on red blood cells
|
Thielen, Astrid J.F.
|
|
2018
|
32 |
4 |
p. 280-288
|
artikel
|
| 6 |
Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review
|
Bertoletti, Laurent
|
|
2018
|
32 |
4 |
p. 272-279
|
artikel
|
| 7 |
Review of immune tolerance induction in hemophilia A
|
Schep, S.J.
|
|
2018
|
32 |
4 |
p. 326-338
|
artikel
|
| 8 |
Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?
|
Hazendonk, H.C.A.M.
|
|
2018
|
32 |
4 |
p. 265-271
|
artikel
|
Tijdschrift beschrijving